These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1938100)
1. Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockade. Moore GJ; Ganter RC; Goghari MH; Franklin KJ Int J Pept Protein Res; 1991 Jul; 38(1):1-7. PubMed ID: 1938100 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan. Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin). Goghari MH; Franklin KJ; Moore GJ J Med Chem; 1986 Jun; 29(6):1121-4. PubMed ID: 3754902 [TBL] [Abstract][Full Text] [Related]
4. An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids. Samanen J; Cash T; Narindray D; Brandeis E; Adams W; Weideman H; Yellin T; Regoli D J Med Chem; 1991 Oct; 34(10):3036-43. PubMed ID: 1920354 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine. Hondrelis J; Matsoukas J; Cordopatis P; Ganter RC; Franklin KJ; Moore GJ Int J Pept Protein Res; 1991 Jan; 37(1):21-6. PubMed ID: 2045217 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7. Matsoukas JM; Agelis G; Hondrelis J; Yamdagni R; Wu Q; Ganter R; Smith JR; Moore D; Moore GJ J Med Chem; 1993 Apr; 36(7):904-11. PubMed ID: 8464045 [TBL] [Abstract][Full Text] [Related]
7. Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupole. Moore GJ; Ganter RC; Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Wilkinson S; Sandall J; Fowler P J Mol Recognit; 1994 Dec; 7(4):251-6. PubMed ID: 7734150 [TBL] [Abstract][Full Text] [Related]
8. Localization of central angiotensin II receptors with [125I]-sar1, ile8-angiotensin II: periventricular sites of the anterior third ventricle. Healy DP; Maciejewski AR; Printz MP Neuroendocrinology; 1986; 44(1):15-21. PubMed ID: 3785574 [TBL] [Abstract][Full Text] [Related]
9. Role of Lys215 located in the fifth transmembrane domain of the AT2 receptor in ligand-receptor interaction. Pulakat L; Tadessee AS; Dittus JJ; Gavini N Regul Pept; 1998 Jan; 73(1):51-7. PubMed ID: 9537673 [TBL] [Abstract][Full Text] [Related]
10. Importance of the N-terminal domain of the type II angiotensin antagonist sarmesin for receptor blockade. Matsoukas J; Cordopatis P; Belte U; Goghari MH; Ganter RC; Franklin KJ; Moore GJ J Med Chem; 1988 Jul; 31(7):1418-21. PubMed ID: 2455051 [TBL] [Abstract][Full Text] [Related]
11. A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin II. Scanlon MN; Matsoukas JM; Franklin KJ; Moore GJ Life Sci; 1984 Jan; 34(4):317-21. PubMed ID: 6546405 [TBL] [Abstract][Full Text] [Related]
12. Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta using a slowly dissociating antagonist [Sar1,Ile8]ANG II for receptor blockade. Scanlon MN; Moore GJ J Pharmacol Methods; 1988 Nov; 20(3):207-24. PubMed ID: 3236889 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists. Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570 [TBL] [Abstract][Full Text] [Related]
14. Structure-desensitization relationships of angiotensin analogues in the rat isolated uterus. Moore GJ; Franklin KJ; Nystrom DM; Goghari MH Can J Physiol Pharmacol; 1985 Aug; 63(8):966-71. PubMed ID: 4075269 [TBL] [Abstract][Full Text] [Related]
15. Reciprocal modulation of the binding of angiotensin agonists and antagonists to angiotensin receptors in smooth muscle. Koziarz P; Beck J; Moore GJ Gen Pharmacol; 1993 May; 24(3):705-13. PubMed ID: 8365653 [TBL] [Abstract][Full Text] [Related]
16. Differences in backbone structure between angiotensin II agonists and type I antagonists. Matsoukas JM; Agelis G; Wahhab A; Hondrelis J; Panagiotopoulos D; Yamdagni R; Wu Q; Mavromoustakos T; Maia HL; Ganter R J Med Chem; 1995 Nov; 38(23):4660-9. PubMed ID: 7473593 [TBL] [Abstract][Full Text] [Related]
17. Conformational restriction of angiotensin II: cyclic analogues having high potency. Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273 [TBL] [Abstract][Full Text] [Related]
18. Structure-function analyses of brain angiotensin control of pressor action in rats. Wright JW; Jensen LL; Roberts KA; Sardinia MF; Harding JW Am J Physiol; 1989 Dec; 257(6 Pt 2):R1551-7. PubMed ID: 2604011 [TBL] [Abstract][Full Text] [Related]
19. Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta with the novel competitive antagonist sarmesin. Scanlon MN; Moore GJ Pharmacology; 1988; 37(3):137-47. PubMed ID: 3227047 [TBL] [Abstract][Full Text] [Related]
20. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa. De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]